Hebrew University one of 25 institutions involved in new European Vascular Genomi...( lial dysfunction that plays a crucial r...)

Hebrew University one of 25 institutions involved in new European Vascular Genomics Network

lial dysfunction that plays a crucial role in the development of atherosclerosis (the endothelium is the inner lining of blood vessels);

2. Instability of the atherosclerotic plaque that is the main cause of arterial thrombus (blood clot) formation leading to coronary artery occlusion and heart attack (the atherosclerotic plaque is an accumulation of scar tissue, blood cells, cholesterol, and other fatty substances into the artery wall; the buildup of plaque narrows the arteries and slows the flow of blood);

3. Therapeutic angiogenesis that opens avenues for novel treatment of heart disease meant to improve cardiac oxygenation and reduce heart failure (angiogenesis is the science that studies the formation of new vessels which would improve cardiac blood perfusion).

Each of the three areas has the potential for the development of new diagnostic and therapeutic strategies that will provide permanent benefits for patients.

'"/>

Contact: Jerry Barach
jerryb@savion.huji.ac.il
972-2-5882904
The Hebrew University of Jerusalem
12-May-2004

Page: 1 2
Related medicine news :

1. New protein discovered by Hebrew University researchers
2. Hebrew University researcher finds sweet way to help prevent heart disease
3. Cancer cell detection technology wins Kaye Award for Hebrew University researchers
4. Novel delivery method for nutrients wins Kaye Innovation Award for Hebrew university students
5. New dressing for wounds developed at Hebrew University
6. Antiepileptic drug developed at Hebrew University to undergo phase three clinical trials
7. New biological sensors for detecting blood glucose developed by Hebrew University, U.S. Scientists
8. Hebrew University student developing drug to treat epilepsy, migraines, chronic pain
9. Indiana University researchers closer to helping hearing-impaired using stem cells
10. Boston University team finds link between high cholesterol and better cognitive performance
11. University seeks recruits for arthritis study

Post Your Comments:

(Date:12/13/2013)... 2013: Echocardiography with conventional M-mode and 2D modalities ... increases the accuracy of pre-participation sports screening, according ... Alexander Kisko from Presov, Slovakia. , EuroEcho-Imaging 2013 ... Association of Cardiovascular Imaging (EACVI), a registered branch ... takes place during 11-14 December in Istanbul, Turkey, ...

(Date:12/12/2013)... mHealthSummit 2013 – Washington ... and Aventyn Inc. announced a collaboration ... remote monitoring platform and Vital Connect HealthPatch MD biosensor ... to help clinicians better manage chronic disease patient populations, ... readmissions. , Vital Connect is an industry pioneer of ...

(Date:12/12/2013)... More than one third of younger, early stage breast ... emission tomography (PET), computed tomography (CT), nuclear medicine bone ... time of staging and diagnosis, according to research from ... , Presented at a poster session at the 2013 ... M.D., assistant professor in MD Anderson,s Breast Medical Oncology, ...

(Date:12/12/2013)... 2013 Price Chopper Supermarkets has ... to innovative health services and screenings at new, ... throughout Upstate New York. , The Health ... pharmacies, and provide free blood pressure, weight, heart ... patients can create a Personal Health Assessment that ...

(Date:12/12/2013)... Atlanta, GA (PRWEB) December 12, 2013 Restless ... 's Andrew Scholtz, from Summerville, SC, Colton Pack from Danese, ... sang duets and America’s choice for them. They competed against ... sing tonight and are voted to go on to the ... Restless Road was, “That’s My Kind of Night” by Luke ...

Breaking Medicine News(10 mins):Health News:New screening strategy to prevent cardiovascular complications in sports 2 Health News:New screening strategy to prevent cardiovascular complications in sports 3 Health News:Vital Connect, Aventyn Launch Wearable Biosensor Platform for Mobile Patient Monitoring 2 Health News:Vital Connect, Aventyn Launch Wearable Biosensor Platform for Mobile Patient Monitoring 3 Health News:Vital Connect, Aventyn Launch Wearable Biosensor Platform for Mobile Patient Monitoring 4 Health News:Younger, early breast cancer patients often undergo unnecessary staging, imaging procedures at time 2 Health News:Younger, early breast cancer patients often undergo unnecessary staging, imaging procedures at time 3 Health News:Price Chopper and CDPHP Partner to Provide Innovative Health Services in Supermarket Pharmacies 2 Health News:Andrew Scholz (AMTC Grad) and Restless Road Battle For A Spot in the Finals On Fox’s X-Factor Finals Tonight 7/8c 2

[0] New screening strategy to prevent cardiovascular complications in sports [0] Vital Connect, Aventyn Launch Wearable Biosensor Platform for Mobile Patient Monitoring [0] Younger, early breast cancer patients often undergo unnecessary staging, imaging procedures at time [0] Price Chopper and CDPHP Partner to Provide Innovative Health Services in Supermarket Pharmacies [0] Andrew Scholz (AMTC Grad) and Restless Road Battle For A Spot in the Finals On Fox’s X-Factor Finals Tonight 7/8c

(Date:12/12/2013)... Dec. 12, 2013 The Muscular Dystrophy ... grant under the auspices of its Bridge-to-Industry ... promising researchers in translational research by providing experience ... research refers to the process of "translating" laboratory ... http://photos.prnewswire.com/prnh/20120424/DC93207LOGO ) "The Bridge ...

(Date:12/12/2013)... -- A new national survey released today by ... are highly satisfied with their specialty pharmacies, but ... and capability" to provide the same medications to ... qualified to do so, according to the survey. ... new "Any Willing Specialty Pharmacy" mandates that would ...

(Date:12/12/2013)... 12, 2013 BioTrends Research Group, one of the ... issues, finds that physician-reported patient shares for Novartis,s Gilenya ... percent among relapsing-remitting multiple sclerosis (RR-MS) patients treated with ... France , Germany , ... and the United Kingdom )—significantly higher ...

Breaking Medicine Technology:MDA Awards Second 'Bridge-to-Industry' Grant 2 MDA Awards Second 'Bridge-to-Industry' Grant 3 New Physicians Survey: Most Drugstores Lack the 'Expertise and Capability' to Provide Specialty Medications 2 Surveyed Neurologists Report Significantly Higher Relapsing-Remitting Multiple Sclerosis Patient Shares for Gilenya and Tysabri, Compared With One Year Ago 2 Surveyed Neurologists Report Significantly Higher Relapsing-Remitting Multiple Sclerosis Patient Shares for Gilenya and Tysabri, Compared With One Year Ago 3

[0] MDA Awards Second 'Bridge-to-Industry' Grant [0] New Physicians Survey: Most Drugstores Lack the 'Expertise and Capability' to Provide Specialty Medications [0] Surveyed Neurologists Report Significantly Higher Relapsing-Remitting Multiple Sclerosis Patient Shares for Gilenya and Tysabri, Compared With One Year Ago